Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
47
pubmed:dateCreated
2008-11-26
pubmed:abstractText
Ribonucleotide reductase small subunit p53R2 was identified as a p53 target gene that provides dNTP for DNA damage repair. However, the slow transcriptional induction of p53R2 in RNA may not be rapid enough for prompt DNA damage repair, which has to occur within a few hours of damage. Here, we demonstrate that p53R2 becomes rapidly phosphorylated at Ser(72) by ataxia telangiectasia mutated (ATM) within 30 min after genotoxic stress. p53R2, as well as its heterodimeric partner RRM1, are associated with ATM in vivo. Mutational studies further indicate that ATM-mediated Ser(72) phosphorylation is essential for maintaining p53R2 protein stability and conferring resistance to DNA damage. The mutation of Ser(72) on p53R2 to alanine results in the hyperubiquitination of p53R2 and reduces p53R2 stability. MDM2, a ubiquitin ligase for p53, interacts and facilitates ubiquitination of the S72A-p53R2 mutant more efficiently than WT-p53R2 after DNA damage in vivo. Our results strongly suggest a novel mechanism for the regulation of p53R2 activity via ATM-mediated phosphorylation at Ser(72) and MDM2-dependent turnover of p53R2 dephosphorylated at the same residue.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-10716435, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-10747958, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-10839544, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-11242034, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-11252893, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-11682647, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-11719458, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-11721054, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-12612651, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-12615712, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-12655059, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-14583450, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-14688249, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-15549093, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-15766528, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-16127747, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-16469705, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-16488986, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-16756507, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-16832357, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-17486094, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-17486112, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-17713585, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-17786248, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-17942393, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-18280234, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-8657102, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-9153395, http://linkedlifedata.com/resource/pubmed/commentcorrection/19015526-9861017
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
25
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
18519-24
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage.
pubmed:affiliation
Department of Clinical and Molecular Pharmacology, City of Hope National Medical Center, Duarte, CA 91010-3000, USA. lchang@coh.org
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural